Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Allakos Inc (ALLK)

Allakos Inc (ALLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 113,467
  • Shares Outstanding, K 89,344
  • Annual Sales, $ 0 K
  • Annual Income, $ -185,700 K
  • EBIT $ -186 M
  • EBITDA $ -186 M
  • 60-Month Beta 0.92
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.58

Options Overview Details

View History
  • Implied Volatility 232.29% ( -22.19%)
  • Historical Volatility 95.62%
  • IV Percentile 51%
  • IV Rank 21.34%
  • IV High 1,062.85% on 10/15/24
  • IV Low 6.90% on 02/29/24
  • Put/Call Vol Ratio 0.67
  • Today's Volume 200
  • Volume Avg (30-Day) 358
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 9,729
  • Open Int (30-Day) 14,385

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.16
  • Number of Estimates 3
  • High Estimate -0.12
  • Low Estimate -0.19
  • Prior Year -0.71
  • Growth Rate Est. (year over year) +77.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8836 +42.60%
on 11/27/24
1.3800 -8.70%
on 12/20/24
+0.3658 (+40.91%)
since 11/26/24
3-Month
0.5750 +119.13%
on 09/27/24
1.5550 -18.97%
on 11/11/24
+0.6845 (+118.94%)
since 09/26/24
52-Week
0.5350 +135.51%
on 09/23/24
3.3600 -62.50%
on 01/10/24
-1.4700 (-53.85%)
since 12/26/23

Most Recent Stories

More News
Allakos Provides Business Update and Reports Third Quarter 2024 Financial Results

ALLK : 1.2600 (-0.79%)
Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers

ALLK : 1.2600 (-0.79%)
Why Shares of Allakos Are Up Wednesday

The stock is bouncing back from a recent 52-week low.

ALLK : 1.2600 (-0.79%)
Why Allakos Stock Skyrocketed Nearly 9% Higher Today

The company is poised to report a critical set of clinical data in the coming months.

ALLK : 1.2600 (-0.79%)
Why Allakos Stock Was Heating Up Today

A notable analyst upgrade had investors piling into this clinical-stage biotech stock today.

PIPR : 305.98 (+0.81%)
ALLK : 1.2600 (-0.79%)
Why Allakos Stock Is on Fire Today

Investors appear to be getting into position ahead of a major upcoming catalyst.

ALLK : 1.2600 (-0.79%)
Allakos Provides Business Update and Reports Second Quarter 2022 Financial Results

SAN CARLOS, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing lirentelimab...

ALLK : 1.2600 (-0.79%)
Allakos Announces the Appointment of Dr. Amy Ladd to its Board of Directors

SAN CARLOS, Calif., July 25, 2022 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing lirentelimab...

ALLK : 1.2600 (-0.79%)
INVESTIGATION REMINDER: The Schall Law Firm Announces Investigation of Breaches of Fiduciary Duties by Management of Allakos Inc.– ALLK

The Schall Law Firm, a national shareholder rights litigation firm, announces it is investigating potential breaches of fiduciary duties by the management of Allakos, Inc. (“Allakos”) (NASDAQ: ALLK...

ALLK : 1.2600 (-0.79%)
INVESTIGATION ALERT: The Schall Law Firm Announces Investigation of Breaches of Fiduciary Duties by Management of Allakos Inc.– ALLK

The Schall Law Firm, a national shareholder rights litigation firm, announces it is investigating potential breaches of fiduciary duties by the management of Allakos, Inc. (“Allakos”) (NASDAQ: ALLK...

ALLK : 1.2600 (-0.79%)

Business Summary

Allakos Inc. is a clinical stage bio-technology company. It discovers and develops therapeutic antibodies for the treatment of allergic, inflammatory and proliferative diseases. Allakos Inc. is based in CA, United States.

See More

Key Turning Points

3rd Resistance Point 1.3633
2nd Resistance Point 1.3267
1st Resistance Point 1.2933
Last Price 1.2600
1st Support Level 1.2233
2nd Support Level 1.1867
3rd Support Level 1.1533

See More

52-Week High 3.3600
Fibonacci 61.8% 2.2808
Fibonacci 50% 1.9475
Fibonacci 38.2% 1.6141
Last Price 1.2600
52-Week Low 0.5350

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar